Total submissions: 6
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Invitae | RCV000196821 | SCV000254724 | likely benign | Long QT syndrome | 2023-10-13 | criteria provided, single submitter | clinical testing | |
| Gene |
RCV000486245 | SCV000573996 | uncertain significance | not provided | 2023-05-09 | criteria provided, single submitter | clinical testing | Has not been previously published as pathogenic or benign to our knowledge; Located in exon 38, which is reported as being expressed in a brain-specific transcript (Otto et al, 1991; Cunha et al, 2008; Wu et al, 2015); In silico analysis supports that this missense variant does not alter protein structure/function |
| Illumina Laboratory Services, |
RCV001145633 | SCV001306323 | uncertain significance | Cardiac arrhythmia, ankyrin-B-related | 2018-01-12 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. |
| Ambry Genetics | RCV002415855 | SCV002680294 | likely benign | Cardiovascular phenotype | 2019-09-04 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
| Fulgent Genetics, |
RCV001145633 | SCV002786152 | uncertain significance | Cardiac arrhythmia, ankyrin-B-related | 2021-09-28 | criteria provided, single submitter | clinical testing | |
| Center for Computational Biology & Bioinformatics, |
RCV004567438 | SCV005049960 | uncertain significance | Meniere disease | 2024-06-03 | no assertion criteria provided | research |